Auriga
Auriga USA is a research and trading platform that focuses on growth sectors within the Health Care and Technology verticals. We operate out of our main office in New York City, and also have satellite offices in Boston, San Francisco, Philadelphia, San Diego, and Washington D.C. This regional network helps us to keep abreast of key corporate developments, enhance client relationships, and provide more efficient product distribution to meet clients' investment needs. The firm is committed to providing our clients with critical information flow, investment ideas, and access to industry experts.
View Older Stories View More Recent Stories
-
Alchimer Rebrands as aveni; Enters Technology Commercialization Phase
-
NADL - North Atlantic Drilling Ltd. secures contract for West Phoenix
-
Theraclion Receives an Additional Financing of €1.1 Million from Bpifrance’s "Industrial Strategic Innovation" Program
-
SuperSonic Imagine Appoints Philippe Lutman as Executive Vice President and Chief Customer Fulfilment Officer
-
SuperSonic Imagine Announces the Appointment of Bernard Doorenbos as President of Supervisory Board
-
SuperSonic Imagine Announces Regulatory Clearance of the Next-Generation Aixplorer(R) Ultrasound System in Japan
-
SuperSonic Imagine Announces Regulatory Clearance of the Next-Generation Aixplorer® Ultrasound System in Japan
-
Gran Tierra announces new executive appointments
-
SuperSonic Imagine Announces Clinical Data From Its Retrospective Multicenter Trial Evaluating ShearWave(TM) Elastography for the Non-Invasive Staging of Patients With Chronic Liver Disease
-
SuperSonic Imagine Announces Clinical Data From Its Retrospective Multicenter Trial Evaluating ShearWave™ Elastography For The Non-invasive Staging Of Patients With Chronic Liver Disease
-
Northern Gold Strengthens Board of Directors
-
SuperSonic Imagine's ShearWave(TM) Elastography Technology Will be Presented at the International Liver Congress (EASL) 2015 Vienna, Austria
-
SuperSonic Imagine’s ShearWave™ Elastography Technology Will be Presented at the International Liver Congress (EASL) 2015
-
SuperSonic Imagine: Sales Growth in Q1 2015: +11% to €3.2 Million
-
FMC Corporation Completes Acquisition of Cheminova A/S
-
SuperSonic Imagine's Aixplorer(R) Ultrasound System Highlighted at AIUM/WFUMB 2015
-
SuperSonic Imagine’s Aixplorer® Ultrasound System Highlighted at AIUM/WFUMB 2015
-
SuperSonic Imagine Appoints Tom Egelund as President and Chief Executive Officer
-
SuperSonic Imagine Appoints Tom Egelund as President and Chief Executive Officer
-
Jacques Souquet, Founder and CEO of SuperSonic Imagine, is Elected to the National Academy of Technologies of France
-
Dr. Barry Goldberg Honored With The SuperSonic Imagine Achievement Award
-
Dr. Barry Goldberg Honored With The SuperSonic Imagine Achievement Award
-
CoLucid Pharmaceuticals Announces Relocation of Company Headquarters to Massachusetts
-
SuperSonic Imagine Appoints Jérôme Destoppeleir as Chief Financial Officer
-
Supersonic Imagine: 2014 Annual Results
-
SuperSonic Imagine: 2014 Annual Results
-
Wunderlich Expands Fixed Income Capital Markets Sales and Trading Teams with Key Hires
-
Seadrill Partners (SDLP) Announces 8M Common Units Offering
-
Notable Mergers and Acquisitions of the Day 9/8: (GE) (FMC) (GCA)/(MGAM) (RAX)/(CTL)
-
FMC Corporation (FMC) to Acquire Denmark's Cheminova for $1.8B
-
Seadrill Partners LLC (SDLP) Closes $1.1B Add-On Senior Secured Term Loan B
-
Moody's Affirms Seadrill Partners LLC (SDLP) at 'Ba3'; Notes Weak Q1 Performance
-
Notable Mergers and Acquisitions of the Day 03/12: (EXXI)/(EPL) (BRK-A)/(GHC) (SDRL)/(SDLP)
-
Seadrill Partners (SDLP) Announces 10.4M Common Unit Offering
-
Seadrill (SDRL) to Sell Auriga Stake (SDLP)
-
SEC Charges Merrill Lynch With Misleading Investors in CDOs; Firm Agrees to $131 Million Settlement (BAC)
-
Auriga Reiterates a 'Buy' on Patterson Companies (PDCO); Revenue Growth from All Segments
-
Auriga Reiterates a 'Buy' on Thermo Fisher Scientific (TMO); Takeaways From Analyst Day
-
Auriga Maintains a 'Buy' on Trina Solar (TSL); Trying To Add Things Up
-
Auriga Maintains a 'Hold' on Suntech Power (STP); Survival Economics at Play
-
Auriga Maintains a 'Buy' on Herbalife (HLF); Spark From Additional Licenses in China
-
Auriga Cuts PT and Estimates on HEICO (HEI); Cautious on Decelerating FSG Growth
-
Auriga Reiterates a 'Buy' on DSW Inc. (DSW); Raising Estimates and PT After Great Q1
-
UPDATE: Auriga Starts Teva Pharma (TEVA) at Hold; Sidelined Until New CEO Is Convincing
-
UPDATE: Auriga Upgrades Lifepoint Holdings (LPNT) to Buy; Use Recent Pullback As Opportunity
-
UPDATE: Auriga Starts Akorn (AKRX) at Buy; Unique Product Portfolio with Limited Competition
-
Notable Analyst Rating Changes 05/23: (SBUX) (AMAT) (WMB) Upgraded; (NDAQ) (PSO) (ARBA) Downgraded
-
Streetinsider.com's Hot Lunchtime Reads 05/22: (FMCN) (RF) (FB) (JPM) (CHK) (DRYS)
-
Auriga Maintains a 'Buy' on Myriad Genetics (MYGN); Understanding Two Areas of Concern
-
Auriga Maintains a 'Buy' on Spirit AeroSystems (SPR); Immune from Broader Defense Worries

